Clarius Group, LLC: IWM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Clarius Group, LLC on IWM, newest first. How the timeline and the estimate are built.
Clarius Group, LLC held 8,529 IWM shares at 2025-12-31 per its 13F-HR filed 2026-01-14.
the latest 13F is the newest step
- period ended2025-12-3113F 8,529 sharesChange vs previous 13F -13 shares
0.12% of the 13F portfolio, value $2,099,430.
13F-HR 0001664214-26-000002 filed by Clarius Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 8,542 sharesChange vs previous 13F 0 shares
0.12% of the 13F portfolio, value $2,066,915.
13F-HR 0001664214-25-000013 filed by Clarius Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 8,542 sharesChange vs previous 13F -500 shares
0.11% of the 13F portfolio, value $1,843,300.
13F-HR 0001664214-25-000009 filed by Clarius Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 9,042 sharesChange vs previous 13F +5,901 shares
0.11% of the 13F portfolio, value $1,803,754.
13F-HR 0001664214-25-000007 filed by Clarius Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 3,141 sharesChange vs previous 13F 0 shares
0.05% of the 13F portfolio, value $694,035.
13F-HR 0001664214-25-000002 filed by Clarius Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 3,141 sharesChange vs previous 13F not available
0.05% of the 13F portfolio, value $693,815.
13F-HR 0001664214-24-000014 filed by Clarius Group, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).